Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis

M Yanada, K Matsuo, N Emi… - … International Journal of …, 2005 - Wiley Online Library
BACKGROUND The efficacy of allogeneic hematopoietic stem cell transplantation (allo‐
HSCT) from a human leukocyte antigen‐identical sibling donor remains controversial for …

[HTML][HTML] Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia …

D Salvatore, M Labopin, A Ruggeri, G Battipaglia… - …, 2018 - ncbi.nlm.nih.gov
Allogeneic hematopoietic stem cell transplantation is the optimal care for patients with high-
risk or intermediate-acute myeloid leukemia. In patients lacking matched sibling donor …

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission

A Rashidi, M Hamadani, MJ Zhang, HL Wang… - Blood …, 2019 - ashpublications.org
HLA-haploidentical hematopoietic cell transplantation (Haplo-HCT) using
posttransplantation cyclophosphamide (PT-Cy) has improved donor availability. However, a …

Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis

M Eapen, V Rocha, G Sanz, A Scaradavou… - The lancet …, 2010 - thelancet.com
Background Umbilical-cord blood (UCB) is increasingly considered as an alternative to
peripheral blood progenitor cells (PBPCs) or bone marrow, especially when an HLA …

Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute …

O Ringden, M Labopin, A Bacigalupo… - Journal of Clinical …, 2002 - ascopubs.org
PURPOSE: Several studies show that allogeneic peripheral blood stem cells (PBSCs)
engraft more rapidly than bone marrow (BM). However, the data are inconsistent with regard …

Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first …

RB Walter, JM Pagel, TA Gooley, EW Petersdorf… - Leukemia, 2010 - nature.com
Hematopoietic cell transplantation (HCT) from a matched related donor (MRD) benefits
many adults with acute myeloid leukemia (AML) in first complete remission (CR1). The …

[HTML][HTML] Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia

J Moore, I Nivison-Smith, K Goh, D Ma… - Biology of Blood and …, 2007 - Elsevier
Recent studies have shown comparable survival outcomes for unrelated donor (URD) stem
cell transplantation in chronic myelogenous leukemia compared to sibling donors. We …

[HTML][HTML] Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high-risk acute …

Y Wang, DH Liu, LP Xu, KY Liu, H Chen… - Biology of Blood and …, 2011 - Elsevier
The outcomes of an historic comparison of 117 consecutive, high-risk, acute leukemia
patients undergoing hematopoietic stem cell transplantation (HSCT) from HLA-mismatched …

Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1

J Versluis, M Labopin, A Ruggeri, G Socie… - Blood …, 2017 - ashpublications.org
Allogeneic hematopoietic stem cell transplantation (alloHSCT) remains the treatment of
choice to consolidate remission in patients with poor-risk acute myeloid leukemia (AML) …

Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from …

A Nagler, M Labopin, M Houhou, M Aljurf… - Journal of Hematology & …, 2021 - Springer
Background Non-T-cell depleted haploidentical hematopoietic stem cell transplantation
(HaploSCT) is being increasingly used in acute lymphoblastic leukemia (ALL) with …